From Evidence to Optimal Management of GEP-NETs Focus on Recent Landmark Trials, NCCN Guidelines, and Patient-Centric Factors for Extending Progression-Free Survival in Patients with GI NETs - Philip Agop Philip, MD, PhD, FRCP - Program Chair